See more : Jsa Technology Société anonyme (MLJSA.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Firebrick Pharma Limited (FRE.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Firebrick Pharma Limited, a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
You may be interested
- BlackRock Sustainable American Income Trust plc (BRSA.L) Income Statement Analysis – Financial Results
- NEC Capital Solutions Limited (8793.T) Income Statement Analysis – Financial Results
- Radius Gold Inc. (RDU.V) Income Statement Analysis – Financial Results
- Quanergy Systems, Inc. (QNGY-WT) Income Statement Analysis – Financial Results
- CleanSpace Holdings Limited (CSX.AX) Income Statement Analysis – Financial Results
Firebrick Pharma Limited (FRE.AX)
About Firebrick Pharma Limited
Firebrick Pharma Limited engages in the development and commercialization of nasal spray treatment for the common cold under the Nasodine name in Australia. The company was incorporated in 2012 and is based in Melbourne, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 14.52K | 830.00 | 4.12K | 422.00K | 508.98K | 0.00 |
| Cost of Revenue | 37.30K | 0.00 | 0.00 | 520.00 | 301.00 | 451.00 |
| Gross Profit | -22.78K | 830.00 | 4.12K | 421.48K | 508.68K | -451.00 |
| Gross Profit Ratio | -156.88% | 100.00% | 100.00% | 99.88% | 99.94% | 0.00% |
| Research & Development | 1.91M | 4.09M | 2.22M | 1.13M | 1.63M | 1.06M |
| General & Administrative | 217.83K | 292.16K | 503.95K | 857.63K | 36.65K | 0.00 |
| Selling & Marketing | 256.08K | 367.78K | 325.37K | 233.92K | 19.38K | 0.00 |
| SG&A | 473.91K | 2.76M | 829.32K | 1.73M | 378.97K | 116.37K |
| Other Expenses | 0.00 | 21.72K | 1.08M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.66M | 6.86M | 4.88M | 2.86M | 2.01M | 1.17M |
| Cost & Expenses | 3.69M | 6.86M | 4.88M | 2.86M | 2.01M | 1.17M |
| Interest Income | 16.98K | 39.95K | 1.28K | 759.00 | 524.00 | 3.14K |
| Interest Expense | 1.01K | 0.00 | 4.14K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 7.18K | 9.52K | 6.94K | 520.00 | 301.00 | 451.00 |
| EBITDA | -1.08M | -6.81M | -3.50M | -2.44M | -1.50M | -1.17M |
| EBITDA Ratio | -7,469.32% | -825,809.64% | -91,785.35% | -678.03% | -394.45% | 0.00% |
| Operating Income | -944.06K | -6.86M | -3.79M | -2.86M | -2.01M | -1.17M |
| Operating Income Ratio | -6,500.86% | -826,956.63% | -91,953.59% | -678.15% | -394.51% | 0.00% |
| Total Other Income/Expenses | -231.81K | 39.95K | -4.14K | 759.00 | 524.00 | 3.14K |
| Income Before Tax | -1.18M | -6.82M | -3.80M | -2.86M | -2.01M | -1.17M |
| Income Before Tax Ratio | -8,097.12% | -822,143.61% | -92,054.07% | -677.97% | -394.41% | 0.00% |
| Income Tax Expense | 0.00 | -21.72K | 1.08M | -422.00K | -508.98K | -444.98K |
| Net Income | -1.18M | -6.80M | -3.80M | -2.44M | -1.50M | -725.26K |
| Net Income Ratio | -8,097.12% | -819,526.75% | -92,054.07% | -577.97% | -294.41% | 0.00% |
| EPS | -0.01 | -0.04 | -0.02 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | -0.04 | -0.02 | -0.01 | -0.01 | 0.00 |
| Weighted Avg Shares Out | 179.03M | 170.09M | 168.84M | 168.84M | 168.84M | 168.84M |
| Weighted Avg Shares Out (Dil) | 179.02M | 170.09M | 168.84M | 168.84M | 168.84M | 168.84M |
No news found for: FRE.AX
Source: https://incomestatements.info
Category: Stock Reports